$LLY positioning for next leg up. Eli Lilly showing momentum signals worth watching for entry. GLP-1 franchise continues to drive institutional accumulation. Risk/reward favors longs here if broader pharma sector holds support.
Avertissement : comprend des opinions de tiers. Il ne s’agit pas d’un conseil financier. Peut inclure du contenu sponsorisé.Consultez les CG.